360iResearch Logo
Global Clinical Trials Market
Report Code: MRR-DA05154 | Publishing Date: July 2020 | Number of Pages: 236

FEATURED COMPANIES

  1. Charles River Laboratory
  2. Chiltern International Ltd.
  3. Clinipace
  4. Eli Lilly and Company
  5. ICON PLC
  6. IQVIA
  7. Novo Nordisk A/S
  8. PAREXEL International Corporation
  9. Pfizer Inc.
  10. Pharmaceutical Product Development, LLC
  11. PRA Health Sciences
  12. SGS SA
  13. Syneos Health
  14. Wuxi AppTec Inc.

The Global Clinical Trials Market to grow from USD 41,963.49 Million in 2019 to USD 68,854.13 Million by 2025, at a Compound Annual Growth Rate (CAGR) of 8.60%.

Market Segmentation & Coverage:

The research report categorizes the Clinical Trials Market to forecast the revenues and analyze the trends in each of the following segments:

"The Treatment Study is projected to witness the highest growth during the forecast period"

Based on Design, the Clinical Trials Market studied across Observational Study and Treatment Study. The Observational Study further studied across Case Control Study, Cohort Study, Cross Sectional Study, and Ecological Study. The Treatment Study further studied across Adaptive Clinical Trial, Non-randomized Control Trial, and Randomized Control Trial. The Observational Study commanded the largest size in the Clinical Trials Market in 2019, followed by the Treatment Study. On the other hand, the Treatment Study expected to grow at the fastest CAGR during the forecast period.

"The Phase II is projected to witness the highest growth during the forecast period"

Based on Phase, the Clinical Trials Market studied across Phase I, Phase II, Phase III, and Phase IV. The Phase III commanded the largest size in the Clinical Trials Market in 2019, followed by the Phase II. On the other hand, the Phase II expected to grow at the fastest CAGR during the forecast period.

"The Oncology is projected to witness the highest growth during the forecast period"

Based on Indication, the Clinical Trials Market studied across Autoimmune/Inflammation, CNS condition, Cardiovascular, Diabetes, Obesity, Oncology, and Pain management. The Autoimmune/Inflammation commanded the largest size in the Clinical Trials Market in 2019, followed by the Oncology. On the other hand, the Oncology expected to grow at the fastest CAGR during the forecast period.

Based on Geography, the Clinical Trials Market studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas region surveyed across Argentina, Brazil, Canada, Mexico, and United States. The Asia-Pacific region surveyed across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, South Korea, and Thailand. The Europe, Middle East & Africa region surveyed across France, Germany, Italy, Netherlands, Qatar, Russia, Saudi Arabia, South Africa, Spain, United Arab Emirates, and United Kingdom.

Market Dynamics:

The factors attributing to the growth of the market are improved clinical trails due to cro consolidation, shift towards patient centric clinical trials, and rising prevalence of diseases. However, some factors such as rising cost of clinical trials and dearth of skilled clinical research professional may hinder the market growth. The Clinical Trials Market expected to showcase the opportunities such as high r&d expenditure by the pharmaceutical industry and demand for clinical trials in the emerging economies. Soon market may face the possible challenges in the growth due to stringent regulations for patient enrollment. However, the key players in the market are putting regressive efforts to provide innovative offerings and benchmark strategies in the market.

Global Clinical Trials Market: Market Dynamics
Global Clinical Trials Market: Market Dynamics

Cumulative Impact of COVID-19:

COVID-19 is an incomparable global public health emergency that has affected almost every industry, so for and, the long-term effects projected to impact the industry growth during the forecast period. Our ongoing research amplifies our research framework to ensure the inclusion of underlaying COVID-19 issues and potential paths forward. The report is delivering insights on COVID-19 considering the changes in consumer behavior and demand, purchasing patterns, re-routing of the supply chain, dynamics of current market forces, and the significant interventions of governments. The updated study provides insights, analysis, estimations, and forecast, considering the COVID-19 impact on the market.

360iResearch Competitive Strategic Window:

The 360iResearch Competitive Strategic Window analyses the competitive landscape in terms of markets, applications, and geographies. The Competitive Strategic Window helps the vendor define an alignment or fit between their capabilities and opportunities for future growth prospects. During a forecast period, it defines the optimal or favorable fit for the vendors to adopt successive merger and acquisition strategies, geography expansion, research & development, and new product introduction strategies to execute further business expansion and growth.

360iResearch FPNV Positioning Matrix:

The 360iResearch FPNV Positioning Matrix evaluates and categorizes the vendors in the Clinical Trials Market on the basis of Business Strategy (Business Growth, Industry Coverage, Financial Viability, and Channel Support) and Product Satisfaction (Value for Money, Ease of Use, Product Features, and Customer Support) that aids businesses in better decision making and understanding the competitive landscape.

Company Usability Profiles:

The Clinical Trials Market is highly competitive and characterized by the presence of a large number of international and regional players in the market. The market has witnessed increased competition between vendors based on the pricing model, technology differentiation, brand name, quality of service, price differentiation, and technical expertise.

The report profoundly explores the recent significant developments by the leading vendors and innovation profiles in the Global Clinical Trials Market, including Charles River Laboratory, Chiltern International Ltd., Clinipace, Eli Lilly and Company, ICON PLC, IQVIA, Novo Nordisk A/S, PAREXEL International Corporation, Pfizer Inc., Pharmaceutical Product Development, LLC, PRA Health Sciences, SGS SA, Syneos Health, and Wuxi AppTec Inc..

  1. Preface
    1. Objectives of the Study
    2. Market Segmentation & Coverage
    3. Years Considered for the Study
    4. Currency & Pricing
    5. Language
    6. Stakeholders
  2. Research Methodology
    1. Research Process
      1. Define: Research Objective
      2. Determine: Research Design
      3. Prepare: Research Instrument
      4. Collect: Data Source
      5. Analyze: Data Interpretation
      6. Formulate: Data Verification
      7. Publish: Research Report
      8. Repeat: Report Update
    2. Research Execution
      1. Initiation: Research Process
      2. Planning: Develop Research Plan
      3. Execution: Conduct Research
      4. Verification: Finding & Analysis
      5. Publication: Research Report
    3. Research Outcome
  3. Executive Summary
    1. Market Outlook
    2. Design Outlook
    3. Phase Outlook
    4. Indication Outlook
    5. Geography Outlook
    6. Competitor Outlook
  4. Market Overview
    1. Introduction
    2. Clinical Trials Market, By Geography
  5. Market Dynamics
    1. Introduction
    2. Drivers
      1. Rising prevalence of diseases
      2. Shift towards patient centric clinical trials
      3. Improved clinical trails due to CRO consolidation
    3. Restraints
      1. Dearth of skilled clinical research professional
      2. Rising cost of clinical trials
    4. Opportunities
      1. Demand for clinical trials in the emerging economies
      2. High R&D expenditure by the pharmaceutical industry
    5. Challenges
      1. Stringent regulations for patient enrollment
  6. Market Insights
    1. Porters Five Forces Analysis
      1. Threat of New Entrants
      2. Threat of Substitutes
      3. Bargaining Power of Customers
      4. Bargaining Power of Suppliers
      5. Industry Rivalry
    2. Cumulative Impact of COVID-19
    3. Client Customizations
  7. Global Clinical Trials Market, By Design
    1. Introduction
    2. Observational Study
      1. Case Control Study
      2. Cohort Study
      3. Cross Sectional Study
      4. Ecological Study
    3. Treatment Study
      1. Adaptive Clinical Trial
      2. Non-randomized Control Trial
      3. Randomized Control Trial
  8. Global Clinical Trials Market, By Phase
    1. Introduction
    2. Phase I
    3. Phase II
    4. Phase III
    5. Phase IV
  9. Global Clinical Trials Market, By Indication
    1. Introduction
    2. Autoimmune/Inflammation
    3. CNS condition
    4. Cardiovascular
    5. Diabetes
    6. Obesity
    7. Oncology
    8. Pain management
  10. Americas Clinical Trials Market
    1. Introduction
    2. Argentina
    3. Brazil
    4. Canada
    5. Mexico
    6. United States
  11. Asia-Pacific Clinical Trials Market
    1. Introduction
    2. Australia
    3. China
    4. India
    5. Indonesia
    6. Japan
    7. Malaysia
    8. Philippines
    9. South Korea
    10. Thailand
  12. Europe, Middle East & Africa Clinical Trials Market
    1. Introduction
    2. France
    3. Germany
    4. Italy
    5. Netherlands
    6. Qatar
    7. Russia
    8. Saudi Arabia
    9. South Africa
    10. Spain
    11. United Arab Emirates
    12. United Kingdom
  13. 360iResearch Competitive Strategic Window
    1. Introduction
    2. 360iResearch Competitive Strategic Window, by Design
    3. 360iResearch Competitive Strategic Window, by Phase
    4. 360iResearch Competitive Strategic Window, by Indication
    5. 360iResearch Competitive Strategic Window, by Geography
  14. Competitive Landscape
    1. 360iResearch FPNV Positioning Matrix
      1. Quadrants
      2. Business Strategy
      3. Product Satisfaction
    2. 360iResearch Market Ranking Analysis
    3. 360iResearch Market Share Analysis
    4. 360iResearch Competitive Scenario
      1. Merger & Acquisition
      2. Agreement, Collaboration, & Partnership
      3. New Product Launch & Enhancement
      4. Investment & Funding
      5. Award, Recognition, & Expansion
  15. Company Usability Profiles
    1. Charles River Laboratory
    2. Chiltern International Ltd.
    3. Clinipace
    4. Eli Lilly and Company
    5. ICON PLC
    6. IQVIA
    7. Novo Nordisk A/S
    8. PAREXEL International Corporation
    9. Pfizer Inc.
    10. Pharmaceutical Product Development, LLC
    11. PRA Health Sciences
    12. SGS SA
    13. Syneos Health
    14. Wuxi AppTec Inc.
  16. Appendix
    1. Discussion Guide
    2. Edition Details
    3. License Details
    4. Pricing Details

List of Tables

  1. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
  2. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  3. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBSERVATIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CASE CONTROL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY COHORT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CROSS SECTIONAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  8. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ECOLOGICAL STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  9. GLOBAL CLINICAL TRIALS MARKET SIZE, BY TREATMENT STUDY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  10. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ADAPTIVE CLINICAL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  11. GLOBAL CLINICAL TRIALS MARKET SIZE, BY NON-RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  12. GLOBAL CLINICAL TRIALS MARKET SIZE, BY RANDOMIZED CONTROL TRIAL, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  13. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE I, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE II, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  16. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE III, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  17. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE IV, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  18. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  19. GLOBAL CLINICAL TRIALS MARKET SIZE, BY AUTOIMMUNE/INFLAMMATION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  20. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CNS CONDITION, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  21. GLOBAL CLINICAL TRIALS MARKET SIZE, BY CARDIOVASCULAR, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  22. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DIABETES, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  23. GLOBAL CLINICAL TRIALS MARKET SIZE, BY OBESITY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  24. GLOBAL CLINICAL TRIALS MARKET SIZE, BY ONCOLOGY, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  25. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PAIN MANAGEMENT, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  26. AMERICAS CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  27. AMERICAS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  28. AMERICAS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  29. AMERICAS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  30. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  31. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  32. ARGENTINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  33. BRAZIL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  34. BRAZIL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  35. BRAZIL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  36. CANADA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  37. CANADA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  38. CANADA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  39. MEXICO CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  40. MEXICO CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  41. MEXICO CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  42. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  43. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  44. UNITED STATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  45. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  46. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  47. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  48. ASIA-PACIFIC CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  49. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  50. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  51. AUSTRALIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  52. CHINA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  53. CHINA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  54. CHINA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  55. INDIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  56. INDIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  57. INDIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  58. INDONESIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  59. INDONESIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  60. INDONESIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  61. JAPAN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  62. JAPAN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  63. JAPAN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  64. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  65. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  66. MALAYSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  67. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  68. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  69. PHILIPPINES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  70. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  71. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  72. SOUTH KOREA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  73. THAILAND CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  74. THAILAND CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  75. THAILAND CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  76. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2017-2025 (USD MILLION)
  77. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  78. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  79. EUROPE, MIDDLE EAST & AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  80. FRANCE CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  81. FRANCE CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  82. FRANCE CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  83. GERMANY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  84. GERMANY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  85. GERMANY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  86. ITALY CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  87. ITALY CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  88. ITALY CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  89. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  90. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  91. NETHERLANDS CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  92. QATAR CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  93. QATAR CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  94. QATAR CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  95. RUSSIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  96. RUSSIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  97. RUSSIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  98. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  99. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  100. SAUDI ARABIA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  101. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  102. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  103. SOUTH AFRICA CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  104. SPAIN CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  105. SPAIN CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  106. SPAIN CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  107. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  108. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  109. UNITED ARAB EMIRATES CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  110. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2017-2025 (USD MILLION)
  111. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY PHASE, 2017-2025 (USD MILLION)
  112. UNITED KINGDOM CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2017-2025 (USD MILLION)
  113. GLOBAL CLINICAL TRIALS MARKET: SCORES
  114. GLOBAL CLINICAL TRIALS MARKET: BUSINESS STRATEGY
  115. GLOBAL CLINICAL TRIALS MARKET: PRODUCT SATISFACTION
  116. GLOBAL CLINICAL TRIALS MARKET: RANKING
  117. GLOBAL CLINICAL TRIALS MARKET: MERGER & ACQUISITION
  118. GLOBAL CLINICAL TRIALS MARKET: AGREEMENT, COLLABORATION, & PARTNERSHIP
  119. GLOBAL CLINICAL TRIALS MARKET: NEW PRODUCT LAUNCH & ENHANCEMENT
  120. GLOBAL CLINICAL TRIALS MARKET: INVESTMENT & FUNDING
  121. GLOBAL CLINICAL TRIALS MARKET: AWARD, RECOGNITION, & EXPANSION
  122. GLOBAL CLINICAL TRIALS MARKET: EDITION DETAILS
  123. GLOBAL CLINICAL TRIALS MARKET: LICENSE DETAILS
  124. GLOBAL CLINICAL TRIALS MARKET: PRICING DETAILS

List of Figures

  1. GLOBAL CLINICAL TRIALS MARKET: RESEARCH PROCESS
  2. GLOBAL CLINICAL TRIALS MARKET: RESEARCH EXECUTION
  3. GLOBAL CLINICAL TRIALS MARKET SIZE, 2019 VS 2025 (USD MILLION)
  4. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
  5. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
  6. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  7. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  8. COMPETITIVE SCENARIO ANALYSIS IN GLOBAL CLINICAL TRIALS MARKET, BY TYPE
  9. GLOBAL CLINICAL TRIALS MARKET SIZE, 2017-2025 (USD MILLION)
  10. GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2019 VS 2025 (USD MILLION)
  11. GLOBAL CLINICAL TRIALS MARKET: MARKET DYNAMICS
  12. GLOBAL CLINICAL TRIALS MARKET: PORTERS FIVE FORCES ANALYSIS
  13. GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2019 VS 2025 (USD MILLION)
  14. GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2019 VS 2025 (USD MILLION)
  15. GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2019 VS 2025 (USD MILLION)
  16. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY DESIGN, 2025 (USD MILLION)
  17. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY PHASE, 2025 (USD MILLION)
  18. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY INDICATION, 2025 (USD MILLION)
  19. COMPETITIVE STRATEGIC WINDOW FOR GLOBAL CLINICAL TRIALS MARKET SIZE, BY GEOGRAPHY, 2025 (USD MILLION)
  20. GLOBAL CLINICAL TRIALS MARKET: 360IRESEARCH FPNV POSITIONING MATRIX
  21. GLOBAL CLINICAL TRIALS MARKET: 360IRESEARCH MARKET SHARE ANALYSIS

SELECT LICENSE TYPE

Enterprise User License $5949
Corporate User License $4949
Single User License $3949